Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand factor C domain containing 2 like (VWC2L) is a protein-coding gene located on chromosome 2 encoding an extracellular matrix-associated protein that may be involved in the development of nerve cells (neurogenesis) and the formation of bone (bone differentiation and matrix mineralization)[2][3][7][8]. VWC2L is predicted to be part of the AMPA glutamate receptor complex and to be localized in the extracellular region and synapse[3]. It is functionally related to the negative regulation of BMP signaling and the positive regulation of neuron differentiation[3][8]. Diseases associated with VWC2L include Tarsal-Carpal Coalition Syndrome and Sclerosteosis 1[3]. The protein is evolutionarily related to other von Willebrand factor C domain-containing proteins, which are involved in various aspects of cell adhesion, migration, homing, and signal transduction[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor C domain containing 2 like (VWC2L).